Sagentia Group
www.sagentiagroup.comSymbol: GEN.L
Currently trading at: 0p No change
The Sagentia Group is an international technology consulting, development and venturing organisation that was founded 20 years ago. It has played an integral part in the ‘Cambridge Phenomenon’ not least from venturing and spinning out several successful companies including CMR Fuel Cells and Sphere Medical.
Sagentia develops technologies that underpin the future of the widest range of industries. Its key areas of expertise include: engineering, materials, telecommunications, business innovation and electronics.
The Group’s facilities include state-of-the-art laboratories at its HQ in Cambridge and offices in; Frankfurt and Stockholm in Europe; in Boston and Baltimore in the USA, and in Hong Kong.
An established and growing business with more than 200 technology professionals, Sagentia continues to attract the best local and international talent and lead the way for Cambridge-based technology consulting and venture management organisations.
It is listed on the London Stock Exchange. It changed its name from the Generics Group on 23rd October 2006.
Staff
 Dr Alistair Brown, Chief Executive OfficerAlistair was appointed as Chief Executive in 2008. Alistair joined Sagentia in 2000 and previously had responsibility for global Sales and Marketing, as well as being Geschäftsführer of Sagentia GmbH with direct responsibility for Sagentia’s business in the German speaking countries. He has particular experience in the exploitation of technology assets and technology transfer. Much of his commercial and technical experience has been gained working with mainland European organisations at director level. He has a first class degree in Physics and Chemistry and a PhD which involved research in high speed, high resolution image acquisition systems. |
Contact details
Harston
Cambridge
CB22 7GG
Tel: 01223 875200
Fax: 01223 875201
